User profiles for Bojan Biocina
Bojan Biocinadocent , Katedra za kirurgiju , Medicinski fakultet Zagreb; predstojnik , Klinika za kardijalnu Verified email at kbc-zagreb.hr Cited by 2505 |
Influence of intraoperative cerebral oximetry monitoring on neurocognitive function after coronary artery bypass surgery: a randomized, prospective study
OBJECTIVES Postoperative cognitive decline is common after cardiac surgery, but it is often
unrecognized at the time of hospital discharge. However, it has a great impact on patient's …
unrecognized at the time of hospital discharge. However, it has a great impact on patient's …
Cardiac myxoma the great imitators: comprehensive histopathological and molecular approach
Cardiac myxomas are rare benign and slowly proliferating neoplasms of uncertain
histogenesis with heterogeneous histomorphology and variable and sometimes clinically quite …
histogenesis with heterogeneous histomorphology and variable and sometimes clinically quite …
Bleeding risk assessment in patients undergoing elective cardiac surgery using ROTEM® platelet and Multiplate® impedance aggregometry
Impaired platelet function is a major risk factor for peri‐operative bleeding and transfusion.
This prospective, observational study enrolled 101 consecutive patients undergoing elective …
This prospective, observational study enrolled 101 consecutive patients undergoing elective …
[PDF][PDF] Cardiac allograft vasculopathy: diagnosis, therapy, and prognosis
…, Ž Baričević, I Škorak, H Gašparović, B Biočina… - Croatian medical …, 2014 - hrcak.srce.hr
The leading causes of death during the first three years after heart transplantation are
nonspecific graft failure and infections. Nonspecific graft failure may be caused by chronic graft …
nonspecific graft failure and infections. Nonspecific graft failure may be caused by chronic graft …
Topical use of antifibrinolytic agents reduces postoperative bleeding: a double-blind, prospective, randomized study
Objective: Postoperative bleeding is still one of the most common complications of cardiac
surgery. Antifibrinolytic agents successfully reduce bleeding, but there are controversies …
surgery. Antifibrinolytic agents successfully reduce bleeding, but there are controversies …
Rationale and design of the Aortic Valve replAcemenT versus conservative treatment in Asymptomatic seveRe aortic stenosis (AVATAR trial): a randomized …
…, J Bartunek, M Asanin, B Beleslin, B Biocina… - American Heart …, 2016 - Elsevier
Aortic valve replacement (AVR) therapy is an obvious choice for symptomatic severe aortic
stenosis (AS) patients as it improves symptoms, left ventricular function, and survival. The …
stenosis (AS) patients as it improves symptoms, left ventricular function, and survival. The …
De novo aortic regurgitation after continuous-flow left ventricular assist device implantation
… MD, PhD a , Daniel Lovric MD b , Davor Milicic MD, PhD b , Bojan Biocina MD, PhD a …
a financial relationship with Thoratec; Drs Saeed and Biocina with Thoratec and HeartWare. …
a financial relationship with Thoratec; Drs Saeed and Biocina with Thoratec and HeartWare. …
Bleeding risk assessment using whole blood impedance aggregometry and rotational thromboelastometry in patients following cardiac surgery
Excessive bleeding after cardiopulmonary bypass (CPB) is risk factor for adverse outcomes
after elective cardiac surgery (ECS). Differentiating between patients who bleed due to …
after elective cardiac surgery (ECS). Differentiating between patients who bleed due to …
NT-pro-BNP, but not C-reactive protein, is predictive of atrial fibrillation in patients undergoing coronary artery bypass surgery
…, J Vojkovic, R Gabelica, B Biocina… - European journal of …, 2010 - academic.oup.com
Objective: Atrial fibrillation (AF) remains the most commonly observed complication
following myocardial revascularisation surgery. We aimed to evaluate the clinical utility of N-terminal …
following myocardial revascularisation surgery. We aimed to evaluate the clinical utility of N-terminal …
Improved survival of left ventricular assist device carriers in Europe according to implantation eras: results from the PCHF‐VAD registry
…, AJ Flammer, H Gasparovic, B Biocina… - European journal of …, 2022 - Wiley Online Library
Aims Temporal changes in patient selection and major technological developments have
occurred in the field of left ventricular assist devices (LVADs), yet analyses depicting this trend …
occurred in the field of left ventricular assist devices (LVADs), yet analyses depicting this trend …